Our DECODE platform discovers disease-causing antigens, as well as the T cells that recognize those antigens. Our DEPLOY platform allows us to use a highly curated antigen repertoire to create targeted immune medicines that harness the power of highly specific T cells and direct them against those diseases.
The depth and breadth of these platforms, unique in the field, allows us to design superior immune medicines.
With our suite of technologies, we have the ability to design and develop targeted immune medicines.
View Pipeline